News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor (World)
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 11/26/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
uniQure To Host Investor Day In New York City 11/21/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS 11/17/2014
Forward Pharma (FWP) Announces Closing Of Partial Exercise Of Over-Allotment Option 11/17/2014
Actavis (ACT) Successfully Completes Durata Therapeutics, Inc.  (DRTX) Tender Offer 11/17/2014
ISI: Merck & Co. (MRK)’s Zetia News The Rising Tide To Lift All LDL Boats 11/17/2014
If Investors Like Merck & Co. (MRK)'s Zetia Results, They Will Love Esperion Therapeutics, Inc. (ESPR)’s, Says Citi 11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014
Patent Fight Between Amgen (AMGN) And Sanofi (SAN.PA)/Regeneron (REGN) Getting Murkier, Says Analyst 11/14/2014
With Promising New Gout Treatment In Its Pipeline, 2015 Will Be Big Year For CymaBay Therapeutics 11/14/2014
Analyst: Amgen (AMGN)’s Psoriasis Drug Is Superior To Stelara And Sales Will Reflect That 11/13/2014
Roche (RHHBY) Announces Early Tender Results Of Its Debt Tender Offer 11/13/2014
Regeneron (REGN), Sanofi (SAN.PA) Asthma Drug A Potential Blockbuster For Allergies, Says Analyst 11/12/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Citi: Esperion Therapeutics, Inc. (ESPR) Will See Cancer Drug Data By End Of Year 11/11/2014
Gilead Sciences, Inc. (GILD) Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst 11/11/2014
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014
Analyst: Celgene (CELG)’s Drug Pipeline Will Be The Gift That Keeps On Giving 11/10/2014
GENFIT Corp. (ALGFT) To Participate In Three Upcoming Investor Conferences 11/7/2014
TherapeuticsMD, Inc.  (TXMD) Looking At Lower Cash Burn, Higher Upside From Promising HRT Therapies: Cowen 11/7/2014
Bristol-Myers Squibb Company (BMY), Merck & Co. (MRK) Competing Hodgkin’s Drugs Look Comparable, Says Analyst 11/7/2014
Sangui BioTech International Inc. (SGBI) Officially Approved As Trading On OTCQB 11/6/2014
Meda AB (MEDA-A.ST) Extraordinary General Meeting Bulletin 11/6/2014
Pharmacyclics, Inc. (PCYC), AstraZeneca PLC (AZN) Partnership Holds Tumor Promise: Citi 11/6/2014
Galmed Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 7, 2014 In New York City 11/5/2014
Karolinska Development AB Secures Funding From CP Group, A Leading Asian Life Science Investor, And Initiates Preparation For A Convertible Bond Issue 11/5/2014
NeuroDerm Announces Launch Of Initial Public Offering 11/4/2014
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014
Change In The Number Of Shares And Votes In Meda AB (MEDA-A.ST) 10/31/2014
AbbVie (ABBV) Might Go Shopping Again Despite Shire Breakup, Say Company Execs 10/31/2014
Citi: Gilead Sciences, Inc. (GILD) Sees Blockbuster First Weeks Of Harvoni Launch 10/31/2014
Novo Nordisk A/S (NVO) Commits $130 Million In Diabetes Research In Denmark 10/31/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option 10/30/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears" 10/30/2014
Roche Holdings, Inc. Announces Debt Tender Offer 10/30/2014
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO 10/29/2014
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi 10/29/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 10/29/2014
NeuroVive Pharmaceutical AB: Annual General Meeting 2015 And Information About Members Appointed To The Nomination Committee 10/29/2014
Merck & Co. (MRK) Execs “Downplaying” Gilead Sciences, Inc. (GILD)'s Harvoni Competitor, Says Analyst 10/28/2014
Nordic Nanovector – Registered Share Capital Increase 10/28/2014
Amgen (AMGN) Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs 10/28/2014
Citi: Sarepta Therapeutics (SRPT) Will See Competition, Concern Over FDA Delay 10/27/2014
Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P 10/24/2014
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst 10/24/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen 10/24/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014
Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan 10/23/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier 10/23/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts 10/22/2014
Ablynx (ABLYF) Announces Warrant Exercise 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Nine-Month Figures For 2014: Sartorius Grows In Order Intake, Sales Revenue And Earnings 10/21/2014
Tianyin Pharmaceutical Co, Inc. Received Notices Of Non-Compliance From NYSE MKT 10/21/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt 10/21/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts 10/21/2014
DBV Technologies Announces Proposed Global Offering 10/20/2014
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment 10/20/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014
TiGenix Publishes Transparency Notification Pursuant To Article 14 Of The Law Of May 2, 2007 10/17/2014
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000 10/16/2014
Tianyin Pharmaceutical Co, Inc. Provides Update On Filing Of Form 10-K For Fiscal Year Ended June 30, 2014 10/15/2014
Orexo AB (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2014/2015 10/15/2014
Announcement Regarding Submission Of Tender Offer For Shares In Ambit Biosciences 10/15/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma 10/15/2014
Immunodiagnostic Systems Holdings plc Trading Update 10/14/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014
Nextech Venture Invest Announces First Closing Of Oncology Fund IV 10/14/2014
Easton Pharmaceuticals (OP: EAPH) Secures Financing Commitment Towards Closing Of Its Option On Canadian Medical Marijuana Facility And Business 10/14/2014
New Irish Tax Rules Won’t Faze Biotech: Analyst 10/14/2014
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc. (GILD) 10/13/2014
Spinal Atrophy Drug From Isis Pharmaceuticals, Inc. (ISIS) Showing Promise, Says UBS 10/13/2014
DiaGenic ASA: Ex Right To Receive Subscription Rights In The Rights Issue Today, 10 October 2014 10/10/2014
PRAC Decision On Leukemia Drug Good News For Ariad Pharmaceuticals, Inc. (ARIA), Says Analyst 10/10/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi 10/9/2014
Skyepharma PLC (SKYEF) – Interim Management Statement 10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO 10/8/2014
Therapix Biosciences ADRs Begin Trading On The OTCQB® 10/7/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
Medtech Startup Embo Medical Secures €3 Million Investment 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
Piper Jaffray: Companies Should Start Stockpiling Now For Ebola 10/3/2014
JSS Medical Research Announces Equity Investment By Capital Croissance PME (CCPME) 10/2/2014
Perrigo Company (PRGO) Announces Extension Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/1/2014
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN) 9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014
GW Pharmaceuticals Research And Development Day Details 9/29/2014
China Cord Blood Corporation To Hold Annual General Meeting In Hong Kong On December 11, 2014 9/26/2014
Antisense Therapeutics Limited (ANP.AX) Release: Placement And Share Purchase Plan 9/25/2014
ProQR Therapeutics B.V. (PRQR) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/24/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
Inivata Raises £4m To Realise The Potential Of Ctdna Analysis To Improve Cancer Treatment Through Simple Blood Tests 9/23/2014
Skyepharma PLC (SKYEF) Announces Notice Of Early Repayment Of Euro CRC Facility 9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million 9/19/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
Ablynx (ABLYF) Establishes Sponsored Level I ADR Programme In The United States 9/5/2014
Horizon Discovery Group Plc: Notice Of Interim Results 9/3/2014
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Medtronic, Inc. (MDT) Announces 2014 "Global Heroes" Team 8/11/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 7/30/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
IntelGenx Corp. To Host Management Call 7/21/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Cantargia’s Share Issue Of 20 MSEK Fully Subscribed 7/9/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014
Vitrolife (VITR.ST) Release: Conference Call Interim Report 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014
TopoTarget A/S Release: Report Pursuant To The Danish Securities Trading Act, Section 28a 7/1/2014
TopoTarget A/S Release: New Articles Of Association Following Capital Increase 7/1/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Shareholders Of Warnex Inc. (CC:WNX) Approve The Amalgamation With Diagnos Inc. (ADK) 6/27/2014
Endo International plc Announces Pricing Of Private Offering Of Senior Notes 6/26/2014
Endo International plc Announces Proposed Private Offering Of Senior Notes 6/25/2014
Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares 6/25/2014
Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014
Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares 6/24/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014
Neovasc Inc. (NVC) Announces Receipt Of Final Approval To Graduate To The TSX 6/20/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue 6/20/2014
BioAlliance Pharma Has Received Pre-Approval For The Secondary Listing Of The Shares Of The Merged Company On NASDAQ OMX Copenhagen 6/20/2014
AstraZeneca PLC (AZN) Release: Director/PDMR Shareholding 6/19/2014
GW Pharmaceuticals Announces Proposed Public Offering Of ADSs 6/18/2014
China Biologic Products Announces Proposed Public Offering Of Common Stock 6/18/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/17/2014
Articles Of Association For Genmab A/S (GEN.CO) 6/16/2014
Grant Of Warrants To Genmab A/S (GEN.CO) Employees 6/13/2014
200,000 Orion Corporation A-Shares Converted Into B-Shares 6/13/2014
Actavis (ACT) Announces Receipt Of Requisite Consents And Expiration Of Consent Solicitations For Forest Laboratories, Inc. (FRX) Senior Notes 6/13/2014
Biohit B-Shares Subscribed With Stock Options I And II 2013 6/12/2014
Aurinia (ISA.TO) To Commence Trading On Toronto Stock Exchange 6/11/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 6/10/2014
Actavis (ACT) Announces Offering Of Senior Unsecured Notes 6/10/2014
Orexo AB (ORXOF) Publishes Bond Prospectus And Applies For Listing Of Its Bond Loan On NASDAQ OMX Stockholm 6/9/2014
Oriola-KD Corporation Recognizes EUR 74 Million Impairment Charge For Russian Pharmaceutical Wholesale Operating Segment 6/5/2014
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 6/5/2014
New Incentive Plans In The H. Lundbeck A/S (LUN.CO) Group 6/4/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 6/3/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/2/2014
Total Number Of Voting Rights And Share Capital In Bavarian Nordic (BAVA.CO) 6/2/2014
Total Number Of Voting Rights And Share Capital In H. Lundbeck A/S (LUN.CO) As Of 31 May 2014 6/2/2014
BioLineRx Ltd. Enters Into Share Purchase Agreement With Lincoln Park Capital 5/30/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 5/30/2014
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 5/29/2014
Report Of Transactions Of Shares And Related Securities Of Bavarian Nordic (BAVA.CO) By Persons Holding Managerial Responsibilities And/Or Persons/Companies Closely Associated With Such 5/29/2014
Bavarian Nordic (BAVA.CO) Issues New Shares In Connection With Exercise Of Warrants 5/27/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 5/27/2014
TopoTarget A/S Release: Notice To Convene Extraordinary General Meeting 5/27/2014



//-->